{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:11:34Z","timestamp":1792789894487,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015686","name":"The Christie NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmp.2025.105178","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:32:12Z","timestamp":1760063532000},"page":"105178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-8226","authenticated-orcid":false,"given":"Tanuj","family":"Puri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-603X","authenticated-orcid":false,"given":"Tiziana","family":"Rancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-6335","authenticated-orcid":false,"given":"Petra","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Vasquez","family":"osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7533-2988","authenticated-orcid":false,"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Farcy-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chang-Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Avuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"de Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-8124","authenticated-orcid":false,"given":"Elena","family":"Sperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-2687","authenticated-orcid":false,"given":"Liv","family":"Veldeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6503-0011","authenticated-orcid":false,"given":"Sarah","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-8962","authenticated-orcid":false,"given":"Christopher","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"McWilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-9567","authenticated-orcid":false,"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Herk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2025.105178_b0005","unstructured":"Atkins V. Biggest prostate cancer screening trial in decades to start in UK. UK Government 2023. URL: https:\/\/www.gov.uk\/government\/news\/biggest-prostate-cancer-screening-trial-in-decades-to-start-in-uk."},{"key":"10.1016\/j.ejmp.2025.105178_b0010","unstructured":"Cancer treatments: Find out more about treatment data for patients who have received chemotherapy, radiotherapy and surgical tumour resections for their tumour in England. 2025. URL: https:\/\/digital.nhs.uk\/ndrs\/data\/data-outputs\/cancer-data-hub\/cancer-treatments."},{"key":"10.1016\/j.ejmp.2025.105178_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","article-title":"Errors and margins in radiotherapy","volume":"14","author":"Vanherk","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0020","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00345-022-04124-x","article-title":"Incidence of genitourinary complications following radiation therapy for localised prostate cancer","volume":"40","author":"David","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.ejmp.2025.105178_b0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2011.05.052","article-title":"Late Gastrointestinal Toxicities following Radiation Therapy for Prostate Cancer","volume":"60","author":"Kim","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejmp.2025.105178_b0030","unstructured":"Chen G, Austin-Seymour M, Castro J, et al. Dose volume histograms in treatment planning evaluation of carcinoma of the pancreas. Proc Eighth Int Conf Use Comput Radiat Ther 1984:264\u20138."},{"key":"10.1016\/j.ejmp.2025.105178_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2013.10.021","article-title":"Dose\/volume\u2013response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions","volume":"109","author":"Thor","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","article-title":"High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): an Overview","volume":"110","author":"Grimm","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2020.09.054","article-title":"Prostate Stereotactic Body Radiation Therapy: an Overview of Toxicity and Dose Response","volume":"110","author":"Wang","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phro.2020.05.006","article-title":"Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy","volume":"14","author":"Shelley","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2016.04.033","article-title":"A Voxel-based Approach to Explore Local Dose differences Associated with Radiation-Induced Lung damage","volume":"96","author":"Palma","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0065","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac0681","article-title":"Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations","volume":"66","author":"Ebert","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2025.105178_b0070","doi-asserted-by":"crossref","first-page":"S5030","DOI":"10.1016\/S0167-8140(24)01680-3","article-title":"1242: Sensitivity of dose-response mapping model parameters at the bladder and rectum in prostate cancer","volume":"194","author":"Puri","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0075","unstructured":"Puri T, van Herk M, Vasquez Osorio E, et al. Assessing interaction between toxicity outcomes and dose surface maps at the bladder and rectum in prostate cancer patients. USA: Houston; 2023."},{"key":"10.1016\/j.ejmp.2025.105178_b0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2016.10.024","article-title":"Modeling Urinary Dysfunction after External Beam Radiation Therapy of the Prostate using Bladder Dose-Surface Maps: evidence of Spatially Variable Response of the Bladder Surface","volume":"97","author":"Yahya","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijrobp.2019.01.088","article-title":"Voxel-based Analysis for Identification of Urethrovesical Subregions predicting Urinary Toxicity after Prostate Cancer Radiation Therapy","volume":"104","author":"Mylona","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2020.02.028","article-title":"Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects","volume":"147","author":"Mylona","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0095","doi-asserted-by":"crossref","unstructured":"Gioscio E, Cicchetti A, Iacovacci J, et al. Bladder dose surface maps identify subregions associated to late toxicities after prostate cancer RT. Track, Vienna, Austria: Radiomics Model. Stat. Methods Phys; 2023.","DOI":"10.1016\/S0167-8140(23)67014-8"},{"key":"10.1016\/j.ejmp.2025.105178_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109868","article-title":"Voxel-based analysis: Roadmap for clinical translation","volume":"188","author":"McWilliam","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.juro.2012.08.091","article-title":"Severe Genitourinary Toxicity following Radiation Therapy for Prostate Cancer\u2014How Long does it last?","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ejmp.2025.105178_b0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2019.04.034","article-title":"REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer","volume":"138","author":"Seibold","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0115","unstructured":"O\u2019Connell M. Automatic image Segmentation using Deep Convolutional Neural Networks \u2013 A White Paper; 2020."},{"key":"10.1016\/j.ejmp.2025.105178_b0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.phro.2022.11.003","article-title":"Evaluating the Effectiveness of Deep Learning Contouring across Multiple Radiotherapy Centres","volume":"24","author":"Walker","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0125","doi-asserted-by":"crossref","unstructured":"Van Herk M, De Jaeger K, De Munck J, Hoogeman M, Meinders J, Ploeger L, et al. A delineation system for N modalities \u2014 software aspects. In: Schlegel W, Bortfeld T, editors. Use Comput. Radiat. Ther., Berlin, Heidelberg: Springer Berlin Heidelberg; 2000, p. 73\u20135. https:\/\/doi.org\/10.1007\/978-3-642-59758-9_27.","DOI":"10.1007\/978-3-642-59758-9_27"},{"key":"10.1016\/j.ejmp.2025.105178_b0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1118\/1.598485","article-title":"A general methodology for three\u2010dimensional analysis of variation in target volume delineation","volume":"26","author":"Remeijer","year":"1999","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2025.105178_b0135","article-title":"Dose-response mapping of bladder and rectum in prostate cancer patients undergoing radiotherapy with and without baseline toxicity correction","volume":"35","author":"Puri","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0140","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2025.105178_b0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13014-014-0275-6","article-title":"Hypofractionated radiotherapy for prostate cancer","volume":"9","author":"Hegemann","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3857\/roj.2021.01032","article-title":"Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients","volume":"40","author":"Nanos","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ejmp.2025.105178_b0160","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(15)00567-7","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial","volume":"17","author":"Aluwini","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2022.08.030","article-title":"The Fraction size Sensitivity of late Genitourinary Toxicity: Analysis of Alpha\/Beta (\u03b1\/\u03b2) Ratios in the CHHiP Trial","volume":"115","author":"Brand","year":"2023","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","article-title":"Consequential late effects in normal tissues","volume":"61","author":"D\u00f6rr","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13014-022-02010-9","article-title":"Variability of \u03b1\/\u03b2 ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy","volume":"17","author":"Cui","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ijrobp.2014.08.347","article-title":"Modelling the Impact of Fractionation on late Urinary Toxicity after Postprostatectomy Radiation Therapy","volume":"90","author":"Fiorino","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1748-717X-8-293","article-title":"Multiple comparisons permutation test for image based data mining in radiotherapy","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2014.02.012","article-title":"A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity","volume":"111","author":"Barnett","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0195","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad088","article-title":"Large-scale meta\u2013genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types","volume":"7","author":"Naderi","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.ejmp.2025.105178_b0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2021.12.040","article-title":"Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation","volume":"167","author":"Kishan","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3857\/roj.2020.00556","article-title":"Harnessing genome-wide association studies to minimize adverse radiation-induced side effects","volume":"38","author":"Benitez","year":"2020","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ejmp.2025.105178_b0210","doi-asserted-by":"crossref","unstructured":"Joiner MC, Van Der Kogel AJ, editors. Basic Clinical Radiobiology. 5th ed. Fifth Edition. | Boca Raton, FL\u00a0: CRC Press\/Taylor & Francis Group, [2018]: CRC Press; 2018. https:\/\/doi.org\/10.1201\/9780429490606.","DOI":"10.1201\/9780429490606"},{"key":"10.1016\/j.ejmp.2025.105178_b0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional Outcomes and Complications following Radiation Therapy for Prostate Cancer: a critical Analysis of the Literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejmp.2025.105178_b0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2016.02.025","article-title":"First application of a pixel-wise analysis on bladder dose\u2013surface maps in prostate cancer radiotherapy","volume":"119","author":"Palorini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0225","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ejmp.2016.08.013","article-title":"Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer","volume":"32","author":"Improta","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2025.105178_b0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of Dose to the Bladder Trigone on Long-Term Urinary Function after High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer. Int","volume":"88","author":"Ghadjar","year":"2014","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","article-title":"Urinary Obstruction in Prostate Cancer patients from the Dutch Trial (68 Gy vs. 78 Gy): Relationships with Local Dose, Acute Effects, and Baseline Characteristics. Int","volume":"78","author":"Heemsbergen","year":"2010","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0240","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.radonc.2018.07.027","article-title":"Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy","volume":"129","author":"Rossi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmp.2016.03.003","article-title":"Predicting toxicity in radiotherapy for prostate cancer","volume":"32","author":"Landoni","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2025.105178_b0250","doi-asserted-by":"crossref","first-page":"S1882","DOI":"10.1016\/S0167-8140(23)67014-8","article-title":"PO-2099 Bladder dose surface maps identify subregions associated to late toxicities after prostate cancer RT","volume":"182","author":"Gioscio","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0284186X.2016.1246801","article-title":"Accuracy requirements and uncertainties in radiotherapy: a report of the International Atomic Energy Agency","volume":"56","author":"Van Der Merwe","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0260","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2020.12.041","article-title":"Estimates of Alpha\/Beta (\u03b1\/\u03b2) Ratios for Individual late Rectal Toxicity Endpoints: an Analysis of the CHHiP Trial","volume":"110","author":"Brand","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0265","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2022.02.009","article-title":"How Low can you go?","volume":"34","author":"Brand","year":"2022","journal-title":"The Radiobiology of Hypofractionation Clin Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"Van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0275","doi-asserted-by":"crossref","first-page":"S5037","DOI":"10.1016\/S0167-8140(24)01786-9","article-title":"1378: Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method","volume":"194","author":"Gioscio","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0280","doi-asserted-by":"crossref","unstructured":"T. Rancati E. Gioscio M.C. Massi et al. Genetically-based analysis of dose surface maps for assessing toxicity post-RT 2024 Lyon, France.","DOI":"10.1016\/S0167-8140(24)01786-9"},{"key":"10.1016\/j.ejmp.2025.105178_b0285","unstructured":"Rancati T. Dose-response mapping at the bladder in prostate cancer patients undergoing radiotherapy: Success, challenges, and future direction. Presented at RadioGenomics Consortium Annual Meeting, 10. Denmark: Aarhus University Hospital, Aarhus; 2024 Oct."},{"key":"10.1016\/j.ejmp.2025.105178_b0290","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0295","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3389\/fonc.2020.01174","article-title":"Increased Dose to Organs in Urinary Tract Associates with measures of Genitourinary Toxicity in Pooled Voxel-based Analysis of 3 Randomized phase III Trials","volume":"10","author":"Marcello","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijrobp.2009.04.040","article-title":"Relating Dose outside the Prostate with Freedom from failure in the Dutch Trial 68 Gy vs. 78 Gy. Int","volume":"77","author":"Witte","year":"2010","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2025.105178_b0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.ejmp.2025.105178_b0310","doi-asserted-by":"crossref","unstructured":"Dewey ME, Seneta E. Carlo Emilio Bonferroni. In: Heyde CC, Seneta E, Cr\u00e9pel P, Fienberg SE, Gani J, editors. Stat. Centuries, New York, NY: Springer New York; 2001, p. 411\u20134. https:\/\/doi.org\/10.1007\/978-1-4613-0179-0_88.","DOI":"10.1007\/978-1-4613-0179-0_88"},{"key":"10.1016\/j.ejmp.2025.105178_b0315","unstructured":"Westfall PH, Young SS. Resampling-based multiple testing: Examples and methods for p-value adjustment, vol. 279. John Wiley & Sons; 1993."}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:07:10Z","timestamp":1762567630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179725002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"alternative-id":["S1120179725002881"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105178","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105178"}}